DSD-C043

Congenital adrenal hyperplasia · DSD-C043

DSD-C043 · Congenital adrenal hyperplasia · 2022

Phenotypes HPO:0000047, HPO:0000786, Hypospadias (HP:0000047), Primary amenorrhea (HP:0000786)

The diagnosis of CAH, the simple-virilizing type, was made. µg/dL; >700 µg/dL suggests androgen-secreting adrenal tumors) was raised but 17-hydroxyprogesterone (17-OHP) at 55 ng/dL (<200 ng/dL excludes the diagnosis; >800 ng/dL is diagnostic, intermediate result require adrenocorticotropic hormone (ACTH) stimulation test) was low, which was against the diagnosis of CAH.

Images · 2

Case fields and evidence

Category

Congenital adrenal hyperplasia

Age

13-year-old

Sex

Unreported

Phenotypes

Hypospadias (HP:0000047); Primary amenorrhea (HP:0000786)

Diagnosis

The diagnosis of CAH, the simple-virilizing type, was made. µg/dL; >700 µg/dL suggests androgen-secreting adrenal tumors) was raised but 17-hydroxyprogesterone (17-OHP) at 55 ng/dL (<200 ng/dL excludes the diagnosis; >800 ng/dL is diagnostic, intermediate result require adrenocorticotropic hormone (ACTH) stimulation test) was low, which was against the diagnosis of CAH.

Follow-up

Unreported

General phenotype

On general examination, signs of virilization were present, such as acne, frontal balding, deepening of the voice, breast atrophy (Tanner stage 2), and hirsutism. According to the modified Ferriman-Gallwey scoring system, her hirsutism score was 27, which comes under the severe category (<8 is considered mild, 8-15 as moderate, and >15 as severe) (Figure 1). To manage hirsutism, shaving, plucking, and waxing were suggested.

Imaging

At that time, laboratory investigation for karyotyping was done along with an ultrasound. The CT scan showed adrenal hyperplasia (Figure 4).

Laboratory findings

testosterone: 97.40 ng/dL (reference: unreported; time point: as reported in original case)

Management

We prescribed tablet hydrocortisone at a dose of 10 mg in the morning and 20 mg in the evening for three months (the recommended dose is 12-18 mg/m2 daily to maintain serum 17-OHP level at 400-1,200 ng/dL).

Pathology

Unreported

Evidence level

See source

Clinical history

See source

Perinatal history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Puberty / Tanner

See source

Karyotype

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia · DSD-C043 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C043?version=v1.4.0